activity
20212026
most citedBaySize: Bayesian Sample Size Planning for Phase I Dose-Finding Trials

2 citations · 2 across the 4 of their papers we have counts for

collaborators

5 papers

stat.ME2026

Interpreting Hierarchical Composite Endpoints with Survival and Longitudinal Outcomes: Application to Amyotrophic Lateral Sclerosis Trials

Arlina Shen, Dehua Bi, Ruben P. A. van Eijk +2

Hierarchical composite endpoints combining survival and longitudinal functional outcomes are increasingly used in clinical trials, especially when death precludes subsequent functi…

stat.ME2024

BESS: A Bayesian Estimator of Sample Size

Dehua Bi, Yuan Ji

We consider a Bayesian framework for estimating the sample size of a clinical trial. The new approach, called BESS, is built upon three pillars: Sample size of the trial, Evidence…

stat.ME2023

PAM-HC: A Bayesian Nonparametric Construction of Hybrid Control for Randomized Clinical Trials Using External Data

Dehua Bi, Tianjian Zhou, Wei Zhong +1

It is highly desirable to borrow information from external data to augment a control arm in a randomized clinical trial, especially in settings where the sample size for the contro…

stat.ME2023

A Class of Dependent Random Distributions Based on Atom Skipping

Dehua Bi, Yuan Ji

We propose the Plaid Atoms Model (PAM), a novel Bayesian nonparametric model for grouped data. Founded on an idea of `atom skipping', PAM is part of a well-established category of…

stat.ME2021★ 2 cited

BaySize: Bayesian Sample Size Planning for Phase I Dose-Finding Trials

Xiaolei Lin, Jiaying Lyu, Shijie Yuan +2

We propose BaySize, a sample size calculator for phase I clinical trials using Bayesian models. BaySize applies the concept of effect size in dose finding, assuming the MTD is defi…